RFK Jr.'s plan for changing the U.S. food and drug system
Robert F. Kennedy Jr., an environmental and anti-vaccine activist, was selected by President-elect Donald Trump to lead the ...
New FDA rules for TV drug ads: Simpler language and no distractions
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...
FDA's New Rules Require TV Drug Ads to Be Clearer, More Direct
The U.S. Food and Drug Administration ( FDA) now requires TV and radio drug ads to be clearer and more direct. The new ...
Fox 1313h
New FDA rules target those ubiquitous TV drug commercials
The agency’s new guidelines are created to eliminate pharmaceutical company practices that minimize or distract consumers ...
Where RFK Jr. could go on food policy
On social media and talk shows, Kennedy repeatedly hammers the food industry, claiming it is “mass poisoning” the American ...
federalnewsnetwork.com14h
FDA sees high vacancy rates for drug manufacturer inspectors
Learn how DLA, GSA’s Federal Acquisition Service and the State Department are modernizing their contract and acquisition ...
WSKG1h
Is it OK to keep reheating leftovers? Honest questions about food safety, illustrated
Protect your loved ones from foodborne illnesses with this refresher course on food safety. Experts offer guidance on how ...
WAMC5h
Don't give your family food poisoning this holiday season. Follow this illustrated guide
Protect your loved ones from foodborne illnesses with this refresher course on food safety. Experts offer guidance on how ...
Healthcare Policies to Watch in the New Trump Administration
Investors and entrepreneurs will track decisions affecting drugs, medical devices and telehealth.
What Robert F. Kennedy Jr. has said about vaccines, fluoride and food dye as Trump nominates him to head the Department of Health and Human Services
President-elect Donald Trump has named Robert F. Kennedy Jr. as his choice for the next secretary of the Department of Health ...
Bristol Myers Gets CHMP Backing for Augtyro Cancer Drug
Bristol Myers Squibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval of its Augtyro cancer drug in a pair of indications.